Efficacy and safety of raltegravir plus lamivudine maintenance therapy
ConclusionsSwitching to raltegravir and lamivudine in PWH with virological suppression maintains efficacy and is well tolerated. This maintenance regimen might be a cost-effective option for PWH at risk of drug –drug interactions or needing to avoid specific toxicities of certain antiretroviral drugs or their negative impact on comorbidities.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research
More News: Chemotherapy | Clinical Trials | Isentress | Microbiology | Sleep Disorders | Sleep Medicine | Toxicology | Virology